Cardiomyopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Lina Yaqoub (talk | contribs) |
No edit summary |
||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
{{CMG}}; {{AE}} [[User:Lina Ya'qoub|Lina Ya'qoub,MD]]; {{EdzelCo}} | |||
==Overview== | |||
Incidence and prevalence differ based on cause. The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population. RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions. | |||
==Cardiomyopathy Epidemiology and Demographics== | |||
Incidence and prevalence differ based on cause.<ref name="pmid12707239">{{cite journal |vauthors=Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M |title=Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy |journal=Circulation |volume=107 |issue=17 |pages=2227–32 |date=May 2003 |pmid=12707239 |doi=10.1161/01.CIR.0000066323.15244.54 |url=}}</ref> | |||
* The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.<ref name="pmid8995091">{{cite journal |vauthors=Kushwaha SS, Fallon JT, Fuster V |title=Restrictive cardiomyopathy |journal=N. Engl. J. Med. |volume=336 |issue=4 |pages=267–76 |date=January 1997 |pmid=8995091 |doi=10.1056/NEJM199701233360407 |url=}}</ref> | |||
* The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population.<ref name="pmid25984311">{{cite journal |vauthors=Kawasaki K, Miyaji K, Kodera S, Suzuki Y, Kanda J, Ikeda M |title=Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia |journal=Clin Case Rep |volume=3 |issue=5 |pages=308–14 |date=May 2015 |pmid=25984311 |doi=10.1002/ccr3.230 |url=}}</ref> | |||
* RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.<ref name="pmid7641357">{{cite journal |vauthors=Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE |title=Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults |journal=Circulation |volume=92 |issue=4 |pages=785–9 |date=August 1995 |pmid=7641357 |doi= |url=}}</ref> | |||
* African–American individuals are approximately three times more prone to development of dilated cardiomyopathy. | |||
* Hypertrophic cardiomyopathy has a prevalence of 400-800 per 100,0000 in adults. This prevalence seems to be similar in all races, but the disease age is mainly considered to be in adolescence and you adults.<ref name="pmid7641357">{{cite journal |vauthors=Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE |title=Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults |journal=Circulation |volume=92 |issue=4 |pages=785–9 |date=August 1995 |pmid=7641357 |doi= |url=}}</ref> | |||
* Dilated cardiomyopathy has an approximate incidence of 4.58 per 100,000 in children less than 1 year old. The incidence decrease when the child ages and is 0.34 per 100,000 between 1 to 18 years old. <ref name="pmid7641357">{{cite journal |vauthors=Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE |title=Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults |journal=Circulation |volume=92 |issue=4 |pages=785–9 |date=August 1995 |pmid=7641357 |doi= |url=}}</ref> | |||
* The incidence of dilated cardiomyopathy was estimated to be 400-800 cases per 100,000 individuals worldwide.<ref name="pmid12711739">{{cite journal |vauthors=Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD |title=The incidence of pediatric cardiomyopathy in two regions of the United States |journal=N. Engl. J. Med. |volume=348 |issue=17 |pages=1647–55 |date=April 2003 |pmid=12711739 |doi=10.1056/NEJMoa021715 |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
| Line 12: | Line 24: | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 03:26, 27 October 2023
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics |
|
Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lina Ya'qoub,MD; Edzel Lorraine Co, DMD, MD[2]
Overview
Incidence and prevalence differ based on cause. The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population. RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.
Cardiomyopathy Epidemiology and Demographics
Incidence and prevalence differ based on cause.[1]
- The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.[2]
- The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population.[3]
- RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.[4]
- African–American individuals are approximately three times more prone to development of dilated cardiomyopathy.
- Hypertrophic cardiomyopathy has a prevalence of 400-800 per 100,0000 in adults. This prevalence seems to be similar in all races, but the disease age is mainly considered to be in adolescence and you adults.[4]
- Dilated cardiomyopathy has an approximate incidence of 4.58 per 100,000 in children less than 1 year old. The incidence decrease when the child ages and is 0.34 per 100,000 between 1 to 18 years old. [4]
- The incidence of dilated cardiomyopathy was estimated to be 400-800 cases per 100,000 individuals worldwide.[5]
References
- ↑ Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M (May 2003). "Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy". Circulation. 107 (17): 2227–32. doi:10.1161/01.CIR.0000066323.15244.54. PMID 12707239.
- ↑ Kushwaha SS, Fallon JT, Fuster V (January 1997). "Restrictive cardiomyopathy". N. Engl. J. Med. 336 (4): 267–76. doi:10.1056/NEJM199701233360407. PMID 8995091.
- ↑ Kawasaki K, Miyaji K, Kodera S, Suzuki Y, Kanda J, Ikeda M (May 2015). "Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia". Clin Case Rep. 3 (5): 308–14. doi:10.1002/ccr3.230. PMID 25984311.
- ↑ 4.0 4.1 4.2 Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (August 1995). "Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults". Circulation. 92 (4): 785–9. PMID 7641357.
- ↑ Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD (April 2003). "The incidence of pediatric cardiomyopathy in two regions of the United States". N. Engl. J. Med. 348 (17): 1647–55. doi:10.1056/NEJMoa021715. PMID 12711739.